Evidence map›Paper›PMID 32716892›Full record

Observational studyJournal of medical Internet research2020

The Internet Hospital Plus Drug Delivery Platform for Health Management During the COVID-19 Pandemic: Observational Study.

Liang Ding, Qiuru She, Fengxian Chen, Zitong Chen, Meifang Jiang, Huasi Huang, Yujin Li, Chaofeng Liao

Abstract readObservational Study
In one paragraph

Observational study in Journal of medical Internet research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Liang Ding *Clinical Trial and Research Center, People's Hospital of Baoan Shenzhen, Shenzhen, China.ORCID 0000-0003-1323-364X
Qiuru She *Department of Pharmacy, People's Hospital of Baoan Shenzhen, Shenzhen, China.ORCID 0000-0002-3084-7267
Fengxian ChenDepartment of Pharmacy, People's Hospital of Baoan Shenzhen, Shenzhen, China.ORCID 0000-0002-6231-7930
Zitong ChenDepartment of Pharmacy, People's Hospital of Baoan Shenzhen, Shenzhen, China.ORCID 0000-0003-3467-7311
Meifang JiangDepartment of Pharmacy, People's Hospital of Baoan Shenzhen, Shenzhen, China.ORCID 0000-0003-4127-0755
Huasi HuangDepartment of Pharmacy, People's Hospital of Baoan Shenzhen, Shenzhen, China.ORCID 0000-0003-0046-8976
Yujin LiDepartment of Pharmacy, People's Hospital of Baoan Shenzhen, Shenzhen, China.ORCID 0000-0002-4788-1701
Chaofeng LiaoDepartment of Pharmacy, People's Hospital of Baoan Shenzhen, Shenzhen, China.ORCID 0000-0001-6979-0360

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWidespread access to the internet has boosted the emergence of online hospitals. A new outpatient service called "internet hospital plus drug delivery" (IHDD) has been developed in China, but little is known about this platform.

objectiveThe aim of this study is to investigate the characteristics, acceptance, and initial impact of IHDD during the outbreak of COVID-19 in a tertiary hospital in South China.

methodsThe total number of and detailed information on online prescriptions during the first 2 months after work resumption were obtained. Patients' gender, age, residence, associated prescription department, time of prescription, payment, and drug delivery region were included in the analysis.

resultsA total of 1380 prescriptions were picked up or delivered between March 2 and April 20, 2020. The largest group of patients were 36-59 years old (n=680, 49.3%), followed by the 18-35 years age category (n=573, 41.5%). In total, 39.4% (n=544) of the patients chose to get their medicine by self-pickup, while 60.6% (n=836) preferred to receive their medicine via drug delivery service. The top five online prescription departments were infectious diseases (n=572, 41.4%), nephrology (n=264, 19.1%), endocrinology (n=145, 10.5%), angiocardiopathy (n=107, 7.8%), and neurology (n=42, 3%). Of the 836 delivered prescriptions, 440 (52.6%) were sent to Guangdong Province (including 363 [43.4%] to Shenzhen), and 396 (47.4%) were sent to other provinces in China.

conclusionsThe IHDD platform is efficient and convenient for various types of patients during the COVID-19 crisis. Although offline visits are essential for patients with severe conditions, IHDD can help to relieve pressure on hospitals by reducing an influx of patients with mild symptoms. Further efforts need to be made to improve the quality and acceptance of IHDD, as well as to regulate and standardize the management of this novel service.

Indexed as

InternetAdolescentAdultChinaCoronavirus InfectionsCOVID-19Disease OutbreaksDrug PrescriptionsFemaleHumansMaleMiddle AgedPandemicsPneumonia, ViralTelemedicineTertiary Care CentersCOVID-19drug deliveryhealth managementIHDDinternet hospitalinternet hospital plus drug delivery

Identifiers

PMID32716892
PMCPMC7419153

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.